This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Medimmune Limited. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Ann-Charlott Steffen: Innovator in Antibody Development
Introduction
Ann-Charlott Steffen is a prominent inventor based in Cambridge, SE. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. Her work focuses on innovative solutions for diagnosing and treating diseases associated with interleukin-18.
Latest Patents
Ann-Charlott Steffen holds a patent for "Anti-IL-18 antibodies and their uses." This invention provides human, humanized, and/or chimeric antibodies, as well as fragments, derivatives, conjugates, and compositions with a specific binding affinity for interleukin-18. The patent includes the use of these antibodies for diagnosing and treating diseases linked to increased IL-18 activity, particularly in the form of a pharmaceutical composition.
Career Highlights
Steffen is currently associated with Medimmune Limited, where she continues to advance her research and development efforts. Her work has been instrumental in the field of therapeutic antibodies, contributing to the understanding and treatment of various diseases.
Collaborations
Throughout her career, Ann-Charlott has collaborated with notable colleagues, including Steven Godfrey Lane and Martin Schwickart. These partnerships have enhanced her research and expanded the impact of her innovations.
Conclusion
Ann-Charlott Steffen is a trailblazer in the field of antibody development, with a focus on interleukin-18. Her contributions through her patent and collaborations highlight her commitment to advancing medical science.